Last reviewed · How we verify
NCT06286800
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
NA trial testing Transcranial direct current stimulation (tDCS) with OT in Stroke in 80 participants. Currently enrolling.
14 March 2027
Quick facts
| Lead sponsor | The Methodist Hospital Research Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 18 December 2024 |
| Primary completion | 14 March 2027 |
| Estimated completion | 14 September 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Transcranial direct current stimulation (tDCS) with OT
- Sham tDCS with OT
Conditions studied
- Stroke — all drugs for Stroke →
- Chronic Stroke — all drugs for Chronic Stroke →
- Hemorrhage Brain — all drugs for Hemorrhage Brain →
- Ischemic Stroke — all drugs for Ischemic Stroke →
Sponsor
The Methodist Hospital Research Institute
Who can join
Adults 18 to 80, any sex, with Stroke or Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06286800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other The Methodist Hospital Research Institute trials
Trials by the same sponsor.
- NCT07048314 — Stem Cells for Erectile Dysfunction Post RALP · Phase 1, PHASE2 · not yet recruiting
- NCT07283068 — IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA · NA · not yet recruiting
- NCT07218484 — VoiceLove Digital Therapy for Delirium in the ICU · NA · recruiting
- NCT07050771 — Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery · Phase 2 · recruiting
- NCT07182279 — Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer · Phase 1, PHASE2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06286800 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Methodist Hospital Research Institute
- Last refreshed: 2 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06286800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing